Thomas Frisell

34PUBLICATIONS
68CO-AUTHORS
AutoimmunityMedical infection agents (incl. prions)Regenerative medicine (incl. stem cells)Inorganic chemistry not elsewhere classifiedRecommender systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Jun 18, 2026
Comparable Infection Risk of Ocrelizumab and Rituximab in Multiple Sclerosis in a Nationwide Swedish Cohort Study.

|Jun 02, 2026
Comorbidities for Predicting Progression Independent of Relapse Activity in Multiple Sclerosis Treated With B-Cell Depletion.

|Nov 20, 2025
Use of Symptomatic Drug Treatment for Fatigue in Multiple Sclerosis and Patterns of Work Loss.

Simon Englund, Johan Reutfors, Thomas Frisell

|Sep 22, 2025
No evidence for the validity of ICE FALCON.

Arvid Sjölander, Thomas Frisell

|Jul 24, 2025
Completeness and generalizability of the Swedish MS register.

Peter Alping, Thomas Frisell, Anna He

|Sep 28, 2024
A cautionary note on the recently proposed ICE Falcon method.

Arvid Sjölander, Thomas Frisell

Pageof 6

Frequent Collaborators

8 joint publications

Johan Askling

6 joint publications

Hannah Bower

6 joint publications

Peter Alping

5 joint publications

Benedicte Delcoigne